Skip links

Our portfolio

Obloo successfully nurtures one of the widest deep tech start-ups portfolio.

Overview

From the best research centers we created an extensive portfolio of breakthrough start-ups,
attracting foreign investments and qualified employment.

Water-soluble bioplastic with tunable temperature-dependent performances.

Take advantage of the power of AI for a high-quality video experience.

Smart texture enabling motion and gesture control real time. It would be used as working suites for collaborative robotics operations

Portable (flexible, lightweight and low-voltage powered <10V) and large area (30 cm x 30 cm or more) direct radiation detectors.

Novel technology for non-invasive glycemia monitoring, based on a high-sensitivity Radio Frequency (RF) sensor, to retrieve glucose information from alternative corporal fluids, such as sweat, saliva or tears.

ML-guided Directed Evolution,  a novel machine learning method that uses a powerful ad-hoc modelization to obtain extremely accurate predictions for best protein candidate in Drug Discovery.

Making a smarter world: everybody can create, transform and manage connected devices and equipments.

Instant expertise everywhere: integrated AR technology solution to enhance field operations in inspection and maintenance

Fog computing platform with innovative application-aware orchestration of infrastructure’ resources.

Energy storage system which unifies the advantages of high energy density cells (e.g. LiS) and high power density systems (e.g. supercapacitors) to overcome the existing limitation in energy storage

Embedded systems, reimagined. Advanced digital twin for the electrical drive and the automation industry.

Drug the undruggable: the new paradigm for Drug Discovery.

Artificial Intelligence (AI) to the edge of the IOT: design tools that assist developers during the design flow of systems and applications, providing automated optimization for AI onto battery-powered tiny devices (cost <10$).

AI and Deep Learning  based Synthetic Data generators to overcome privacy concerns to fully exploit data value.

A smart medical device on hospitals beds for accurate and continuous monitoring of urine output and early diagnosis of Acute Kidney Injury through machine learning algorithms

100+

Professionals employed

€70M

Cumulated capital raised

8

Foreign investors

(DE, FR, IRL, BE, CH, US)

Do you want to get in touch with us?

Contact us